82 FR 47750 - Agricultural Biotechnology Education and Outreach Initiative; Public Meetings; Request for Comments
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration Federal Register Volume 82, Issue 197 (October 13, 2017)
Food and Drug Administration
Federal Register Volume 82, Issue 197 (October 13, 2017)
| Page Range | 47750-47752 | |
| FR Document | 2017-22172 |
[Federal Register Volume 82, Number 197 (Friday, October 13, 2017)] [Notices] [Pages 47750-47752] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-22172] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2017-N-5991] Agricultural Biotechnology Education and Outreach Initiative; Public Meetings; Request for Comments AGENCY: Food and Drug Administration, HHS. ACTION: Notice of public meetings; request for comments. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration (FDA or we) is announcing the following public meetings entitled ``Agricultural Biotechnology Education and Outreach Initiative.'' The purpose of the public meetings is to provide the public with an opportunity to share information, experiences, and suggestions to help inform the development of this education and outreach initiative. DATES: The public meetings will be held on November 7, 2017, in Charlotte, North Carolina, and on November 14, 2017, in San Francisco, California. Submit either electronic or written comments by November 17, 2017. See the SUPPLEMENTARY INFORMATION section for registration date and information. ADDRESSES: The public meetings will be held at:The Omni Charlotte, 132 East Trade St., Charlotte, NC 28202 on November 7, 2017, and The San Francisco Marriott Marquis, 780 Mission St., San Francisco, CA 94103 on November 14, 2017. You may submit comments as follows. Please note that late, untimely filed comments will not be considered. Electronic comments must be submitted on or before November 17, 2017. The https://www.regulations.gov electronic filing system will accept comments until midnight Eastern Time at the end of November 17, 2017. Comments received by mail/hand delivery/courier (for written/paper submissions) will be considered timely if they are postmarked or the delivery service acceptance receipt is on or before that date. Electronic Submissions Submit electronic comments in the following way: Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https://www.regulations.gov will be posted to the docket unchanged. Because your [[Page 47751]] comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else's Social Security number, or confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your comments, that information will be posted on https://www.regulations.gov. If you want to submit a comment with confidential information that you do not wish to be made available to the public, submit the comment as a written/paper submission and in the manner detailed (see ``Written/Paper Submissions'' and ``Instructions''). Written/Paper Submissions Submit written/paper submissions as follows: Mail/Hand delivery/Courier (for written/paper submissions): Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. For written/paper comments submitted to the Dockets Management Staff, FDA will post your comment, as well as any attachments, except for information submitted, marked and identified, as confidential, if submitted as detailed in ``Instructions.'' Instructions: All submissions received must include the Docket No. FDA-2017-N-5991 for ``Agricultural Biotechnology Education and Outreach Initiative; Public Meetings; Request for Comments.'' Received comments, those filed in a timely manner (see ADDRESSES), will be placed in the docket and, except for those submitted as ``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through Friday. Confidential Submissions--To submit a comment with confidential information that you do not wish to be made publicly available, submit your comments only as a written/paper submission. You should submit two copies total. One copy will include the information you claim to be confidential with a heading or cover note that states ``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' We will review this copy, including the claimed confidential information, in our consideration of comments. The second copy, which will have the claimed confidential information redacted/blacked out, will be available for public viewing and posted on https://www.regulations.gov. Submit both copies to the Dockets Management Staff. If you do not wish your name and contact information to be made publicly available, you can provide this information on the cover sheet and not in the body of your comments and you must identify this information as ``confidential.'' Any information marked as ``confidential'' will not be disclosed except in accordance with 21 CFR 10.20 and other applicable disclosure law. For more information about FDA's posting of comments to public dockets, see 80 FR 56469, September 18, 2015, or access the information at: https://www.thefederalregister.org/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf. Docket: For access to the docket to read background documents or the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in the heading of this document, into the ``Search'' box and follow the prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. FOR FURTHER INFORMATION CONTACT: For questions regarding registration to attend a meeting: Simone Katz, Strategic Results, 101 Lakeforest Blvd., Suite 390, Gaithersburg, MD 20877, 240-449-8427, [email protected]. For all other questions: Juanita Yates, Center for Food Safety and Applied Nutrition, Food and Drug Administration, 5001 Campus Dr., College Park, MD 20740, 240-402-1731, [email protected]. SUPPLEMENTARY INFORMATION: I. Background The Consolidated Appropriations Act, 2017 (Pub. L. 115-31) stipulates that the Commissioner of Food and Drugs, in coordination with the Secretary of Agriculture, will use appropriated funds to provide consumer outreach and education regarding agricultural biotechnology and biotechnology-derived food products and animal feed, including through publication and distribution of science-based educational information on the environmental, nutritional, food safety, economic, and humanitarian impacts of such biotechnology. FDA is responsible for promoting and protecting the public health, including by ensuring that the nation's food supply is safe and nutritious. FDA provides information and outreach to a variety of audiences along with extensive, hands-on food safety and nutrition education programs for educators, health professionals, and consumers. Educational materials are targeted to consumers in general, as well as to specific groups such as children/youth, older Americans, underserved populations, individuals with weakened immune systems (related to food safety), pregnant women, and other subpopulations. To further our public health mission, we develop food safety and nutrition outreach initiatives in conjunction with non-Federal organizations and individuals, including teachers, community leaders, health educators, animal owners, and private and public health professionals, to increase awareness of and provide education on food safety and nutrition. In developing and implementing the Agricultural Biotechnology Education and Outreach Initiative, FDA will coordinate with the U.S. Department of Agriculture (USDA). We also will collaborate with other U.S. Federal Government Agencies, and public and private organizations as needed. These interactions will help us to develop a comprehensive and thorough framework for consumer education and awareness of the environmental, nutritional, food safety, economic, and humanitarian impacts of agricultural biotechnology. We believe public comment will be helpful to inform the development of this education and outreach initiative. II. Topics for Discussion at the Public Meetings FDA is holding two public meetings, one in North Carolina and one in California, to provide the public with an opportunity to provide comments related to FDA's Agricultural Biotechnology Education and Outreach Initiative. We invite the public to share information, experiences, and suggestions that can help inform the development of the education and outreach initiative. We invite interested persons, including those participating in the public meetings, to respond to the following questions specifically regarding agricultural biotechnology and biotechnology-derived food products and animal feed: 1. What are the specific topics, questions, or other information that consumers would find most useful, and why? 2. Currently, how and from where do consumers most often receive information on this subject? 3. How can FDA (in coordination with USDA) best reach consumers with science-based educational information on this subject? The comments received will help FDA identify education goals, messaging, and dissemination strategies [[Page 47752]] for FDA's Agricultural Biotechnology Education and Outreach Initiative. III. Participating in the Public Meeting Registration: To register for a public meeting, please include your name, title, firm name, address, and phone and fax numbers in your registration information and send to: Simone Katz, Strategic Results, 101 Lakeforest Blvd., Suite 390, Gaithersburg, MD 20877, 240-449-8427, Fax: 240-641-9042, email: [email protected]. You can register for one or both meetings. Registration is free and based on space availability, with priority given to early registrants. Persons interested in attending this public meeting must register by October 30, 2017, for the Charlotte, NC, meeting and must register by November 6, 2017, for the San Francisco, CA, meeting. Early registration is recommended because seating is limited; therefore, FDA may limit the number of participants from each organization. Registrants will receive confirmation when they have been accepted. If you need special accommodations due to a disability, please contact Simone Katz, Strategic Results, 101 Lakeforest Blvd., Suite 390, Gaithersburg, MD 20877, 240-449-8427, Fax: 240-641-9042, email: [email protected] no later than October 20, 2017, for the Charlotte, NC, meeting and no later than October 27, 2017, for the San Francisco, CA, meeting. Requests for Oral Presentations: During online registration you may indicate if you wish to present during a public comment session or participate in a specific session, and which topic(s) you wish to address. We will do our best to accommodate requests to make public comments. Individuals and organizations with common interests are urged to consolidate or coordinate their presentations, and request time for a joint presentation, or submit requests for designated representatives to participate in the focused sessions. Following the close of registration, we will determine the amount of time allotted to each presenter and the approximate time each oral presentation is to begin, and will select and notify participants by October 24, 2017, for the meeting in Charlotte, NC, and by November 1, 2017, for the meeting in San Francisco, CA. All requests to make oral presentations must be received by October 20, 2017, for the meeting in Charlotte, NC, and by October 27, 2017, for the meeting in San Francisco, CA. Streaming Webcast of the Public Meeting: Each public meeting will also be webcast. Individuals who wish to participate by webcast are asked to preregister at: https://www.fda.gov/Food/NewsEvents/WorkshopsMeetingsConferences/default.htm If you have never attended a Connect Pro event before, test your connection at https://collaboration.fda.gov/common/help/en/support/meeting_test.htm. To get a quick overview of the Connect Pro program, visit https://www.adobe.com/go/connectpro_overview. FDA has verified the Web site addresses in this document, as of the date this document publishes in the Federal Register, but Web sites are subject to change over time. Transcripts: Please be advised that as soon as a transcript of each public meeting is available, it will be accessible at https://www.regulations.gov. It may be viewed at the Dockets Management Staff (see ADDRESSES). A link to the transcript will also be available on the internet at https://www.fda.gov/Food/NewsEvents/WorkshopsMeetingsConferences/default.htm. Other Issues for Consideration: A summary of key information on participating in a meeting follows: Table 1--Information on Participation in the Meeting -------------------------------------------------------------------------------------------------------------------------------------------------------- Request to make Submit either Date Address Preregister Electronic address an oral Special electronic or presentation accommodations written comments -------------------------------------------------------------------------------------------------------------------------------------------------------- November 7, 2017, from 8:30 Omni Charlotte October 30, 2017: Please preregister at October 20, 2017. October 20, Submit Comments by a.m. to 1 p.m. EST. Hotel, 132 E Closing date for https://www.fda.gov/ 2017: Closing November 17, 2017, Trade St., registration. Food/NewsEvents/ date to request to: https:// Charlotte, NC WorkshopsMeetingsConf special www.regulations.gov, 28202. erences/default.htm. accommodations or Dockets due to a Management Staff disability. (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. November 14, 2017, from 8:30 San Francisco November 6, 2017: Please preregister at October 27, 2017. October 27, Same as above. a.m. to 1 p.m. PST. Marriott Closing date for https://www.fda.gov/ 2017: closing Marquis, 780 registration. Food/NewsEvents/ date to request Mission St., San WorkshopsMeetingsConf special Francisco, CA erences/default.htm. accommodations 94103. due to a disability. -------------------------------------------------------------------------------------------------------------------------------------------------------- You may also register via email, mail, or fax. Please include your name, title, firm name, address, and phone and Fax numbers in your registration information and send to: Simone Katz, Strategic Results, 101 Lakeforest Blvd., Suite 390, Gaithersburg, MD 20877, 240-449-8427, Fax: 240-641-9042, email: [email protected]. Individuals who wish to participate by webcast are asked to preregister at: https://www.fda.gov/Food/NewsEvents/WorkshopsMeetingsConferences/default.htm. Dated: October 6, 2017. Anna K. Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis. [FR Doc. 2017-22172 Filed 10-12-17; 8:45 am] BILLING CODE 4164-01-P
![47750 Federal Register / Vol. 82, No. 197 / Friday, October 13, 2017 / Notices
docket number, found in brackets in the approval procedure’’ with new DEPARTMENT OF HEALTH AND
heading of this document, into the incentives for drug development in the HUMAN SERVICES
‘‘Search’’ box and follow the prompts form of exclusivities and patent term
and/or go to the Dockets Management extensions. With the passage of the Food and Drug Administration
Staff, 5630 Fishers Lane, Rm. 1061, Hatch-Waxman Amendments, the FD&C [Docket No. FDA–2017–N–5991]
Rockville, MD 20852. Act describes different routes for
You may submit comments on any obtaining approval of two broad Agricultural Biotechnology Education
guidance at any time (see 21 CFR categories of drug applications: New and Outreach Initiative; Public
10.115(g)(5)). drug applications (NDAs) and Meetings; Request for Comments
Submit written requests for single abbreviated new drug applications
copies of the draft guidance to the (ANDAs). AGENCY: Food and Drug Administration,
Division of Drug Information, Center for HHS.
This guidance focuses on those ACTION: Notice of public meetings;
Drug Evaluation and Research, Food applications that can be submitted as
and Drug Administration, 10001 New request for comments.
ANDAs under section 505(j) of the
Hampshire Ave., Hillandale Building, FD&C Act, petitioned ANDAs under SUMMARY: The Food and Drug
4th Floor, Silver Spring, MD 20993– section 505(j)(2)(C) of the FD&C Act, or Administration (FDA or we) is
0002. Send one self-addressed adhesive NDAs under section 505(b)(2) of the announcing the following public
label to assist that office in processing FD&C Act. This guidance does not meetings entitled ‘‘Agricultural
your requests. See the SUPPLEMENTARY discuss stand-alone NDAs. Biotechnology Education and Outreach
INFORMATION section for electronic
This draft guidance is being issued Initiative.’’ The purpose of the public
access to the draft guidance document.
consistent with FDA’s good guidance meetings is to provide the public with
FOR FURTHER INFORMATION CONTACT: an opportunity to share information,
practices regulation (21 CFR 10.115).
Elizabeth Giaquinto Friedman, Center experiences, and suggestions to help
The draft guidance, when finalized, will
for Drug Evaluation and Research, Food inform the development of this
represent the current thinking of FDA
and Drug Administration, 10903 New education and outreach initiative.
on factors for applicants to consider
Hampshire Ave., Rm. 1670, Silver DATES: The public meetings will be held
when determining whether to submit an
Spring, MD 20993, 240–402–7930, on November 7, 2017, in Charlotte,
ANDA or a 505(b)(2) application. It does
elizabeth.giaquinto@fda.hhs.gov. North Carolina, and on November 14,
not establish any rights for any person
SUPPLEMENTARY INFORMATION: and is not binding on FDA or the public. 2017, in San Francisco, California.
I. Background You can use an alternative approach if Submit either electronic or written
it satisfies the requirements of the comments by November 17, 2017. See
FDA is announcing the availability of the SUPPLEMENTARY INFORMATION section
applicable statutes and regulations. This
a draft guidance for industry entitled for registration date and information.
guidance is not subject to Executive
‘‘Determining Whether to Submit an
Order 12866. ADDRESSES: The public meetings will be
ANDA or a 505(b)(2) Application.’’ This
held at:
guidance is intended to serve as a II. Paperwork Reduction Act of 1995 • The Omni Charlotte, 132 East Trade
foundational guidance to assist St., Charlotte, NC 28202 on November 7,
applicants in determining which one of This draft guidance refers to
previously approved collections of 2017, and
the abbreviated approval pathways • The San Francisco Marriott
under the FD&C Act is appropriate for information found in FDA regulations.
Marquis, 780 Mission St., San
the submission of a marketing These collections of information are
Francisco, CA 94103 on November 14,
application to FDA. This guidance subject to review by the Office of
2017.
highlights criteria for submitting Management and Budget (OMB) under
You may submit comments as
applications under the abbreviated the Paperwork Reduction Act of 1995
follows. Please note that late, untimely
approval pathways described in section (44 U.S.C. 3501–3520). The collections
filed comments will not be considered.
505(j) and 505(b)(2) of the FD&C Act (21 of information in 21 CFR 314.94 have
Electronic comments must be submitted
U.S.C. 355(j) and 21 U.S.C. 355(b)(2), been approved under OMB control
on or before November 17, 2017. The
respectively), identifies considerations number 0910–0001. The collection of
https://www.regulations.gov electronic
to help potential applicants determine information for controlled
filing system will accept comments
whether an application would be more correspondence and pre-ANDA meeting
until midnight Eastern Time at the end
appropriately submitted under section requests has been approved under OMB
of November 17, 2017. Comments
505(j) or under section 505(b)(2) of the control number 0910–0797.
received by mail/hand delivery/courier
FD&C Act, and provides direction to III. Electronic Access (for written/paper submissions) will be
potential applicants on requesting considered timely if they are
assistance from FDA in making this Persons with access to the Internet postmarked or the delivery service
determination. may obtain the draft guidance at either acceptance receipt is on or before that
The Drug Price Competition and http://www.fda.gov/Drugs/ date.
Patent Term Restoration Act of 1984 GuidanceCompliance
(Pub. L. 98–417) (the Hatch-Waxman RegulatoryInformation/Guidances/ Electronic Submissions
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Amendments) added section 505(b)(2) default.htm or http:// Submit electronic comments in the
and 505(j) of the FD&C Act, which www.regulations.gov. following way:
describe abbreviated approval pathways • Federal eRulemaking Portal:
Dated October 10, 2017.
for drug products regulated by the https://www.regulations.gov. Follow the
Agency under the FD&C Act. The Hatch- Anna K. Abram, instructions for submitting comments.
Waxman Amendments reflect Deputy Commissioner for Policy, Planning, Comments submitted electronically,
Congress’s efforts to balance the need to Legislation, and Analysis. including attachments, to https://
‘‘make available more low cost generic [FR Doc. 2017–22196 Filed 10–12–17; 8:45 am] www.regulations.gov will be posted to
drugs by establishing a generic drug BILLING CODE 4164–01–P the docket unchanged. Because your
VerDate Sep<11>2014 18:05 Oct 12, 2017 Jkt 244001 PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 E:\FR\FM\13OCN1.SGM 13OCN1](https://thefederalregister.org/doc/82_FR_47947/page/1.svg)
![47752 Federal Register / Vol. 82, No. 197 / Friday, October 13, 2017 / Notices
for FDA’s Agricultural Biotechnology Fax: 240–641–9042, email: Streaming Webcast of the Public
Education and Outreach Initiative. simone.katz@strategicresults.com no Meeting: Each public meeting will also
later than October 20, 2017, for the be webcast. Individuals who wish to
III. Participating in the Public Meeting
Charlotte, NC, meeting and no later than participate by webcast are asked to
Registration: To register for a public October 27, 2017, for the San Francisco, preregister at: https://www.fda.gov/
meeting, please include your name, CA, meeting. Food/NewsEvents/
title, firm name, address, and phone and WorkshopsMeetingsConferences/
Requests for Oral Presentations:
fax numbers in your registration default.htm
information and send to: Simone Katz, During online registration you may
If you have never attended a Connect
Strategic Results, 101 Lakeforest Blvd., indicate if you wish to present during a
Pro event before, test your connection at
Suite 390, Gaithersburg, MD 20877, public comment session or participate
https://collaboration.fda.gov/common/
240–449–8427, Fax: 240–641–9042, in a specific session, and which topic(s) help/en/support/meeting_test.htm. To
email: simone.katz@ you wish to address. We will do our get a quick overview of the Connect Pro
strategicresults.com. You can register for best to accommodate requests to make program, visit https://www.adobe.com/
one or both meetings. public comments. Individuals and go/connectpro_overview. FDA has
Registration is free and based on organizations with common interests are verified the Web site addresses in this
space availability, with priority given to urged to consolidate or coordinate their document, as of the date this document
early registrants. Persons interested in presentations, and request time for a publishes in the Federal Register, but
attending this public meeting must joint presentation, or submit requests for Web sites are subject to change over
register by October 30, 2017, for the designated representatives to participate time.
Charlotte, NC, meeting and must register in the focused sessions. Following the Transcripts: Please be advised that as
by November 6, 2017, for the San close of registration, we will determine soon as a transcript of each public
Francisco, CA, meeting. Early the amount of time allotted to each meeting is available, it will be accessible
registration is recommended because presenter and the approximate time at https://www.regulations.gov. It may
seating is limited; therefore, FDA may each oral presentation is to begin, and be viewed at the Dockets Management
limit the number of participants from will select and notify participants by Staff (see ADDRESSES). A link to the
each organization. Registrants will October 24, 2017, for the meeting in transcript will also be available on the
receive confirmation when they have Charlotte, NC, and by November 1, internet at https://www.fda.gov/Food/
been accepted. 2017, for the meeting in San Francisco, NewsEvents/
If you need special accommodations CA. All requests to make oral WorkshopsMeetingsConferences/
due to a disability, please contact presentations must be received by default.htm.
Simone Katz, Strategic Results, 101 October 20, 2017, for the meeting in Other Issues for Consideration: A
Lakeforest Blvd., Suite 390, Charlotte, NC, and by October 27, 2017, summary of key information on
Gaithersburg, MD 20877, 240–449–8427, for the meeting in San Francisco, CA. participating in a meeting follows:
TABLE 1—INFORMATION ON PARTICIPATION IN THE MEETING
Request to Special Submit either electronic or
Date Address Preregister Electronic address make an oral accommoda- written comments
presentation tions
November 7, Omni Charlotte October 30, Please preregister at https:// October 20, October 20, Submit Comments by November
2017, from 8:30 Hotel, 132 E 2017: Closing www.fda.gov/Food/ 2017. 2017: Closing 17, 2017, to: https://
a.m. to 1 p.m. Trade St., date for reg- NewsEvents/ date to re- www.regulations.gov, or Dock-
EST. Charlotte, NC istration. WorkshopsMeetingsConferen- quest special ets Management Staff (HFA–
28202. ces/default.htm. accommoda- 305), Food and Drug Adminis-
tions due to a tration, 5630 Fishers Lane,
disability. Rm. 1061, Rockville, MD
20852.
November 14, San Francisco November 6, Please preregister at https:// October 27, October 27, Same as above.
2017, from 8:30 Marriott Mar- 2017: Closing www.fda.gov/Food/ 2017. 2017: closing
a.m. to 1 p.m. quis, 780 Mis- date for reg- NewsEvents/ date to re-
PST. sion St., San istration. WorkshopsMeetingsConferen- quest special
Francisco, CA ces/default.htm. accommoda-
94103. tions due to a
disability.
You may also register via email, mail, WorkshopsMeetingsConferences/ DEPARTMENT OF HEALTH AND
or fax. Please include your name, title, default.htm. HUMAN SERVICES
firm name, address, and phone and Fax Dated: October 6, 2017.
numbers in your registration Food and Drug Administration
Anna K. Abram,
information and send to: Simone Katz,
Deputy Commissioner for Policy, Planning,
Strategic Results, 101 Lakeforest Blvd., [Docket No. FDA–2017–N–5953]
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Legislation, and Analysis.
Suite 390, Gaithersburg, MD 20877,
240–449–8427, Fax: 240–641–9042,
[FR Doc. 2017–22172 Filed 10–12–17; 8:45 am] Orthopaedic and Rehabilitation
email: simone.katz@ BILLING CODE 4164–01–P Devices Panel of the Medical Devices
strategicresults.com. Advisory Committee; Notice of Meeting
Individuals who wish to participate AGENCY: Food and Drug Administration,
by webcast are asked to preregister at: HHS.
https://www.fda.gov/Food/NewsEvents/ ACTION: Notice.
VerDate Sep<11>2014 18:05 Oct 12, 2017 Jkt 244001 PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 E:\FR\FM\13OCN1.SGM 13OCN1](https://thefederalregister.org/doc/82_FR_47947/page/3.svg)
Document Created: 2017-10-13 04:33:53
Document Modified: 2017-10-13 04:33:53
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of public meetings; request for comments. | |
| Dates | The public meetings will be held on November 7, 2017, in Charlotte, North Carolina, and on November 14, 2017, in San Francisco, California. Submit either electronic or written comments by November 17, 2017. See the SUPPLEMENTARY INFORMATION section for registration date and information. | |
| Contact | For questions regarding registration to attend a meeting: Simone Katz, Strategic Results, 101 Lakeforest Blvd., Suite 390, Gaithersburg, MD 20877, 240-449-8427, [email protected] For all other questions: Juanita Yates, Center for Food Safety and Applied Nutrition, Food and Drug Administration, 5001 Campus Dr., College Park, MD 20740, 240-402-1731, [email protected] | |
| FR Citation | 82 FR 47750 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR